Zura Bio (ZURA)

• Market cap: $250M
• 1 day: 1.05%
• 5 days: 3.78%
• 1 month: 1.86%
• 3 months: 81.13%
• 6 months: 285%
• Year to date: 63.4%
• 1 year: 25.9%
• 5 years: -60.41%
• 10 years: -60.41%
• Sector: Healthcare
• Industry: Biotechnology

About: Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Employees: 30